Outcome of Board Meeting held today i.e., August 02, 2025 for the quarter June 30, 2025
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
MedPlus Health Services reported consolidated revenue from operations of Rs. 15,426.34 million for Q1 FY26 (ended June 30, 2025), up 3.6% from Rs. 14,888.25 million in Q1 FY25. Net profit after tax surged 195% to Rs. 423.43 million from Rs. 143.44 million, with EPS rising to Rs. 3.54 from Rs. 1.20. Profit before tax nearly tripled to Rs. 527.66 million. On the standalone side, PAT grew 46% to Rs. 135.33 million. The Board also appointed M/s M P R & Associates as Cost Auditor for FY26 and M/s R & A Associates as Secretarial Auditors for five years (FY26–FY30). Additionally, 79,157 ESOP shares were allotted (stated as not material), and the 19th AGM was scheduled for September 15, 2025.
Strong earnings growth, with consolidated PAT nearly tripling year-on-year, signals significant margin expansion and improved operating efficiency, likely to be viewed positively by shareholders. Auditor appointments are routine compliance matters and the small ESOP allotment is not material to shareholding.